Key Details
Price
$7.11Annual ROE
-74.67%Beta
3.45Events Calendar
Next earnings date:
Mar 3, 2025Recent quarterly earnings:
Nov 6, 2024Recent annual earnings:
Mar 6, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Jan 21, 25 HC Wainwright & Co.
BuyJan 10, 25 HC Wainwright & Co.
BuyDec 30, 24 HC Wainwright & Co.
BuyNov 7, 24 Benchmark
BuySep 13, 24 Rodman & Renshaw
BuyAug 22, 24 Rodman & Renshaw
BuyAug 16, 24 Benchmark
BuyAug 9, 24 Benchmark
BuyJul 3, 24 Benchmark
BuyJul 2, 24 Benchmark
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Emergent BioSolutions doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Emergent BioSolutions?
- Does Emergent BioSolutions pay dividends?
- What sector is Emergent BioSolutions in?
- What industry is Emergent BioSolutions in?
- What country is Emergent BioSolutions based in?
- When did Emergent BioSolutions go public?
- Is Emergent BioSolutions in the S&P 500?
- Is Emergent BioSolutions in the NASDAQ 100?
- Is Emergent BioSolutions in the Dow Jones?
- When was Emergent BioSolutions's last earnings report?
- When does Emergent BioSolutions report earnings?
- Should I buy Emergent BioSolutions stock now?
What is the ticker symbol for Emergent BioSolutions?
The ticker symbol for Emergent BioSolutions is NYSE:EBS
Does Emergent BioSolutions pay dividends?
No, Emergent BioSolutions does not pay dividends
What sector is Emergent BioSolutions in?
Emergent BioSolutions is in the Healthcare sector
What industry is Emergent BioSolutions in?
Emergent BioSolutions is in the Drug Manufacturers - Specialty & Generic industry
What country is Emergent BioSolutions based in?
Emergent BioSolutions is headquartered in United States
When did Emergent BioSolutions go public?
Emergent BioSolutions's initial public offering (IPO) was on November 15, 2006
Is Emergent BioSolutions in the S&P 500?
No, Emergent BioSolutions is not included in the S&P 500 index
Is Emergent BioSolutions in the NASDAQ 100?
No, Emergent BioSolutions is not included in the NASDAQ 100 index
Is Emergent BioSolutions in the Dow Jones?
No, Emergent BioSolutions is not included in the Dow Jones index
When was Emergent BioSolutions's last earnings report?
Emergent BioSolutions's most recent earnings report was on Nov 6, 2024
When does Emergent BioSolutions report earnings?
The next expected earnings date for Emergent BioSolutions is Mar 3, 2025
Should I buy Emergent BioSolutions stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions